Role of MSCT Volumetry in Assessment of Brain Atrophy in Septic Patients

NCT ID: NCT06112119

Last Updated: 2023-11-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

55 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-01

Study Completion Date

2024-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

assessment of brain atrophy associated with septic ICU patients by using MSCT Volumetry

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sepsis is the leading cause of admission to ICU , the number of patients who survive and discharge from ICU has also increased due to technological advances in ICU however quality of life of these patients after ICU discharge is lower than that of healthy people of a similar age, in particular Sepsis associated encephalopathy associated with brain dysfunction.

We hypothesized that brain damage including brain volume reduction that ocurre in acute phase of Sepsis using CT scan and there finding " relationship to risk factor and outcome".

We compared head CT finding at time of admission with those obtained during the course of the treatment

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sepsis-Associated Encephalopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cohort

patients \>16y with sepsis associated with disturbance in conscious level, the first braun CT scan will be routinely performed on admission, the second further brain CT Scan will be obtained whenever prolonged disturbance of consciousness will be detected.

MSCT

Intervention Type DEVICE

Using Semi-automatic MSCT Volumetry in assessment of brain atrophy associated with septic ICU patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MSCT

Using Semi-automatic MSCT Volumetry in assessment of brain atrophy associated with septic ICU patients

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients \>16years old with sepsis associated with disturbance in conscious level admitted to ICU

Exclusion Criteria

* Age\< 16y Brain death Hematological disease Malignant disease Hypoxemia Error in automatic tissue classification Motion artifac
Minimum Eligible Age

16 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nada Mohamed Abdelmoneim

Assistant Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nada mohamed abdelmoneim

Role: PRINCIPAL_INVESTIGATOR

Assiut University

sherif mohamed abdelaal

Role: STUDY_DIRECTOR

Assiut University

samy abdelaziz

Role: STUDY_DIRECTOR

Assiut University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nada mohamed abdelmoneim

Role: CONTACT

01097151396

sherif mohamed abdelaal

Role: CONTACT

01003691110

References

Explore related publications, articles, or registry entries linked to this study.

Nakae R, Sekine T, Tagami T, Murai Y, Kodani E, Warnock G, Sato H, Morita A, Yokota H, Yokobori S. Rapidly progressive brain atrophy in septic ICU patients: a retrospective descriptive study using semiautomatic CT volumetry. Crit Care. 2021 Nov 29;25(1):411. doi: 10.1186/s13054-021-03828-7.

Reference Type BACKGROUND
PMID: 34844648 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://doi.org/10.1186/s13054-021-03828-7

retrospective study using semi automatic volumetry

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

sepsis and brain atrophy

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sepsis Metabolomics
NCT01649440 COMPLETED